Use this URL to cite or link to this record in EThOS:
Title: Signal transduction in skeletal muscle mediating responses to phenotype altering signals
Author: Atherton, Philip James
Awarding Body: University of Central Lancashire
Current Institution: University of Central Lancashire
Date of Award: 2005
Availability of Full Text:
Access through EThOS:
Access through Institution:
Skeletal muscle phenotype, size and function respond to exercise, disease and ageing. The aim of this thesis was to investigate the signal transduction pathways responsible for selected skeletal muscle phenotype and size changes. Myostatin, recently identified as a negative regulator of muscle mass was exposed at 10 ng ml 4 to C2C12 cells, and using cDNA genome-wide profiling, was shown to act as a transcriptional suppressor. Furthermore, in these cells myostatin significantly (n8, p<0.05) reduced phosphorylation of components in the P1-3K pathway: PKB Ser473 -30 %, mTOR Ser2448 -50 %, p70 S6K Thr389 -60 %, whereas 4E-BP1 Thr37/46 remained unaffected. These data provide insights in to the mechanisms by which myostatin controls muscle mass, through negatively affecting transcription and translation. Differences in the concentrations of signalling proteins often alter cellular function and phenotype, as is evident from numerous heterozygous knock-out models. Whilst the levels of metabolic enzymes differ between fibre types, and are regulable by exercise, it is not known if this is also true of signal transduction proteins. Therefore, it was hypothesised that the relative levels of signalling proteins implicated in the adaptation to exercise in both fast rat extensor digitorum longus (EDL; 3% type I fibres) and slow Soleus (84% type I fibres) would be systematically different. Secondly, it was hypothesised that following 6 weeks of chronic electrical stimulation (CMNS) where the EDL undergoes a fast-to-slow transformation, the relative signalling protein concentrations between control EDL/stimulated EDL would mirror the differences shown in control EDL/Soleus. Finally, that CMNS would induce chronic signalling to produce, and maintain a slower phenotype. Western blots revealed that the concentrations of some proteins such as Calcineurin (2.6-fold) and p38 MAPK (1.36-fold) were higher in EDL, whilst others such as PGC-la (1.4-fold); and NFkB (3-fold) (all n=4, pc0.05) were higher in Soleus. CMNS of EDL also led to changes in protein levels between control EDL/stimulated EDL: AMPK which is higher in Soleus was actually 1.4-fold lower following stimulation of EDL, whereas other proteins such as PGC-la moved in the direction of that of Soleus. CMNS was also able to induce chronic phosphorylation of proteins involved in fibre type and mitochondrial biogenesis, such as AMPK 4 fold, and p38 -4.5-fold. These data show that signal transduction protein concentrations vary between fast and slow muscles, presumably reflecting differences at a fibre level. Furthermore, signalling proteins are regulated by CMNS of EDL, but do not always change in the direction of slow Soleus. Chronic phosphorylation of many signalling proteins can explain the characteristic phenotypic change in response to CMNS. Resistance training stimulates adaptive protein synthesis and hypertrophy whereas endurance training induces a partial fast-to-slow fibre phenotype transformation. To simulate these conditions, isolated rat muscles were stimulated at 25 °C with either high frequency (HFS; 6 x 10 repetitions, 3 s-bursts at 100 Hz to mimic resistance training) or low frequency (LFS; 3 h at 10 Hz to mimic endurance training). HFS significantly increased myofibrillar and sarcoplasmic protein synthesis 3 h after stimulation 5.3 and 2.7-fold, respectively (n=6, p<0.05). LFS had no significant effect on protein synthesis 3 h after stimulation, but increased UCP3 mRNA 11.7-fold, whereas HFS had no significant effect on UCP3 mRNA (n6, p<0.05). Only LFS increased AMPK phosphorylation significantly at Thr172 by 2-fold and increased POC- 1 a protein to 1.3-fold of control. LFS had no effect on PICB phosphorylation but reduced TSC2 phosphorylation at Thr1462 and deactivated translational regulators. In contrast, HFS acutely increased phosphorylation of PKB at Ser473 5.3-fold and the phosphorylation of TSC2, mTOR, GSK-3j3 at PKB-sensitive sites. HFS also caused a prolonged activation of the translational regulators p70 56k, 4E-BPI, eIF2B, and eEF2 (all n=8, p<0.05). This behaviour has been termed the AMPK-PICB switch, and is hypothesised to mediate specific adaptations to endurance and resistance training, respectively. Ageing is associated with a loss of muscle mass tenned sarcopenia. Essential amino acids (EAA) are potent stimulators of muscle protein synthesis (MPS), and therefore defects in EAA-induced anabolism might affect ability to maintain muscle mass in ageing and disease. MPS and signalling responses to EAA-stimulation of 20 fasted young versus 24 elderly subjects (age 28 ± 6 and 70 ± 6; BMI 24 ± 3, 25 ± 4 kg.m 2 respectively; means ± SD) and 8 fasted elderly versus 8 elderly with type II DM (age 66 ± 3 and 70 ± 6; BMI: 25 ± 4 vs. 32 ± 2 kg.m 2, respectively means ± SD) were measured using gas combustion mass spectrometry and Western blotting methods. Basal MPS rates were indistinguishable, but the elderly displayed a reduced anabolic responsiveness of MPS to EAA, possibly due to decreased intramuscular phosphorylation after EAA, of amino acid sensing/signalling proteins mTOR, p70 S6 kinase, 4E-BPI and eIF2Bs by —50 %. This was further exacerbated in elderly with type II DM whom exhibited reduced Ser2448 phosphorylation of mTOR by —50 %, reflecting decreased downstream signalling. Associated with the anabolic deficits were — 4-fold increases in NFiB protein, the inflammation-associated transcription factor, as well as —50 % and —20 % decreases in protein expression of p70 S6K of healthy elderly and elderly with type II DM, respectively. These results suggest that the elderly are unable to mount a full anabolic response to EAA and that this blunting is further pronounced in type II DM.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available